A Study to Evaluate the Pharmacokinetics and Safety of YHD1119 in Subjects With Renal Impairment and Healthy Subjects

NCT05012436 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer
Renal Impairments

Interventions

DRUG: YHD1119 75mg

Sponsor

Yuhan Corporation